Combo, Current Research, Drug, Oncology, Pre-clinical, Prof. Allen, Rare, University of Cambridge
Testing two generic drugs to improve outcomes in osteosarcoma, a rare bone cancer Principal Investigator: Prof. Matthew Allen Disease: Osteosarcoma Research Description: Although osteosarcoma (OSA) is a rare type of cancer, it is the most common bone cancer in...
Adult, CureAccelerator Live!, Current Research, Dr. Phillips, Drug, Minority/Underserved, Oncology, Rare, University of Michigan
Improving Patient Response in Mantle Cell Lymphoma with Venetoclax Principal Investigator: Dr. Tycel Phillips Disease: Mantle cell lymphoma Research Description: Mantle cell lymphoma (MCL) is a rare form of non-Hodgkin lymphoma (NHL) that is diagnosed mostly in older...
Children's Hospital of Philadelphia, Current Research, Diagnostic, Dr. Seif, Drug, Mid-Atlantic, Oncology, Pediatric, Rare
Preventing Relapse After Bone Marrow Transplant in Pediatric Acute Lymphoblastic Leukemia (ALL) with a Personalized Treatment Principal Investigator: Dr. Alix Seif Disease: Acute Lymphoblastic Leukemia Research Description: Pediatric acute lymphoblastic leukemia (ALL)...
Adult, CureAccelerator Live!, Current Research, Nutraceutical, Oncology, Rare, University of California Irvine
Treating a Group of Rare Blood Cancers, Myeloproliferative Neoplasms, with a Nutraceutical Principal Investigator: Dr. Angela Fleischman Disease: Myeloproliferative neoplasms: Polycythemia vera, essential thrombocythemia and myelofibrosis Research Description:...
Completed Research, Dr. Riggins, Drug, Johns Hopkins Medicine, Mid-Atlantic, Oncology, Pediatric, Rare
A Phase I Trial for Recurrent Pediatric Brain Cancers Using a Repurposed Generic Drug Principal Investigator: Dr. Gregory Riggins Disease: Medulloblastoma, Glioblastoma Research Description: Medulloblastoma is the most common malignant brain tumor in children, and...
Adult, Completed Research, Device, Dr. Davalos, Dr. Martin, Mid-Atlantic, Oncology, Rare, Virginia Tech University
Using an Approved Device to Increase the Immune Response in Pancreatic Cancer Patients Principal Investigator: Dr. Rafael Davalos Co-Investigator: Dr. Robert C.G. Martin Disease: Pancreatic Cancer Research Description: Irreversible electroporation (IRE) is a...
